Inventor · disambiguated record
Sean Brady
Also filed as: BRADY SEAN · BRADY SEAN F
7 granted patents·15 pending applications·3 citations·filing 2001–2023
73Inventor score
Top patents by PatentIndex Score
22 records- 0165US9217008B1Anticancer agents of the anthracyclin familyBRADY SEAN·Filed 2014·Granted Dec 22, 2015·2 cites·18 claims
- 0263US2025320248A1Menaquinone-binding compounds and methods of use thereofUNIV ROCKEFELLER·Filed 2022·Application pending·0 cites
- 0363US2025230188A1Metagenome-guided biosynthesis and compounds and methods of use thereofUNIV ROCKEFELLER·Filed 2023·Application pending·0 cites
- 0459US11472843B2Malacidins and methods of useUNIV ROCKEFELLER·Filed 2018·Granted Oct 18, 2022·0 cites·14 claims
- 0558US7115753B2Triaryl cation antibiotics from environmental DNAWISCONSIN ALUMNI RES FOUND·Filed 2003·Granted Oct 3, 2006·1 cites·5 claims
- 0656US9833465B2Anticancer agents of the anthracyclin familyUNIV ROCKEFELLER·Filed 2016·Granted Dec 5, 2017·0 cites·17 claims
- 0756US2010268631A1Structure and mechanism for REIT preferred securitiesFELDMAN LOUIS·Filed 2009·Application pending·0 cites
- 0855US2024207329A1Methods of treating adenocarcinoma with human microbiota derived n-acyl amidesICAHN SCHOOL MED MOUNT SINAI·Filed 2022·Application pending·0 cites
- 0954US9475834B2Anticancer agents of the anthracyclin familyUNIV ROCKEFELLER·Filed 2015·Granted Oct 25, 2016·0 cites·19 claims
- 1054US2023272010A1Antibacterial synthetic-bioinformatic natural products and uses thereofUNIV ROCKEFELLER·Filed 2021·Application pending·0 cites
- 1154US2025346633A1Macolacins and methods of use thereofUNIV ROCKEFELLER·Filed 2022·Application pending·0 cites
- 1252US2009192829A1Variable product reinsuranceLONG CAITLIN·Filed 2008·Application pending·0 cites
- 1349US2008027846A1Substantial equity content trust preferred ("sectrs")BRADY SEAN·Filed 2007·Application pending·0 cites
- 1449US2022175856A1Unraveling receptor-metabolite interactions in the human microbiomeUNIV ROCKEFELLER·Filed 2020·Application pending·0 cites
- 1548US2020113950A1Human microbiota derived N-acyl amides for the treatment of human diseaseUNIV ROCKEFELLER·Filed 2018·Application pending·0 cites
- 1646US2011231341A1Substantial Equity Content Trust Preferred ("SECTRS")BRADY SEAN·Filed 2010·Application pending·0 cites
- 1746US2006242052A1Variable product reinsuranceLONG CAITLIN·Filed 2006·Application pending·0 cites
- 1844US11325920B2Antibacterial compounds, compositions thereof, and methods using sameUNIV ROCKEFELLER·Filed 2019·Granted May 10, 2022·0 cites·20 claims
- 1943US11339184B2Antibacterial compounds, compositions thereof, and methods using sameUNIV ROCKEFELLER·Filed 2020·Granted May 24, 2022·0 cites·30 claims
- 2041US2020306337A1Bioactive Metabolities Encoded by the Human Microbiome Using Primary Sequence AloneUNIV ROCKEFELLER·Filed 2017·Application pending·0 cites
- 2133US2001047029A1Triaryl cation antibiotics from environmental DNAFiled 2001·Application pending·0 cites
- 2226US2018193321A1Indolotryptoline anticancer agentsBRADY SEAN·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sean Brady files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →